Williams, Peter
Gage, Heather
Jones, Bridget
Aspden, Carole
Smylie, Jessica
Bird, Thomas
Touray, Morro M. L.
Brady, Phelim
Campbell, John
Chilvers, Rupa
Marchand, Catherine
Peckham, Stephen
Richards, Suzanne H.
Spilsbury, Karen
Joy, Mark
de Lusignan, Simon
Article History
Received: 19 December 2024
Accepted: 5 March 2025
First Online: 17 May 2025
Declarations
:
: The study was reviewed and approved by the University of Surrey Ethics Committee (UEC 2019 077 FHMS); North of Scotland Research Ethics Services NHS Grampian (19/NS/0188); and NHS Health Research Authority, Health and Care Research Wales (HCRW). The HRA and NHS REC are conducted under the UK Policy Framework for health and social care research; the sources for the framework include International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use, Good Clinical Practice (ICH GCP) and the Declaration of Helsinki. Staff invited to complete the survey were given full participant information and the link to the survey. Before gaining access to the questions, individuals provided informed consent by agreeing to take part in the survey.
: Not applicable.
: The authors declare no competing interests.